Clinical trial
A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.
NCT00454246 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00454246 |
|---|---|
| Title | A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis. |
| Official title | A Randomized, Open Label Study of the Effect of Intravenous Mircera on Hemoglobin Control in Patients Transitioning From Chronic Kidney Disease Stage 4 Through Dialysis |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | methoxy polyethylene glycol-epoetin beta, epoetin alfa, darbepoetin alfa |
| Enrollment | 111 |
| Start date | Apr 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Mar 30, 2007 |
| Last update posted | Dec 16, 2011 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: